<SEC-DOCUMENT>0001157523-19-000034.txt : 20190107
<SEC-HEADER>0001157523-19-000034.hdr.sgml : 20190107
<ACCEPTANCE-DATETIME>20190107080056
ACCESSION NUMBER:		0001157523-19-000034
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190107
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190107
DATE AS OF CHANGE:		20190107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		19512216

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51921394.htm
<DESCRIPTION>HOLOGIC, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2019 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 10pt; font-family: Times New Roman">
    <p>

    </p>
    <hr style="text-align: center; height: 3.0 pt; color: #000000; width: 100%">


    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 14pt"><b>UNITED
      STATES</b></font><b><font style="font-family: Times New Roman; font-size: 14pt"><br style="font-size: 14pt; font-family: Times New Roman"></font><font style="font-family: Times New Roman; font-size: 14pt">SECURITIES
      AND EXCHANGE COMMISSION</font></b><br><font style="font-family: Times New Roman; font-size: 12pt"><b>Washington,
      D.C. 20549</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman"><b>______________</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 18pt"><b>FORM 8-K</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman"><b>______________</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>Current
      Report Pursuant</b></font><br><font style="font-family: Times New Roman; font-size: 12pt"><b>to
      Section 13 or 15(d) of the</b></font><br><font style="font-family: Times New Roman; font-size: 12pt"><b>Securities
      Exchange Act of 1934</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt"><b>Date of
      Report (Date of earliest event reported) January 7, 2019</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman"><b>______________</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 22pt"><b>HOLOGIC,
      INC.</b></font><br><font style="font-family: Times New Roman; font-size: 10pt"><b>(Exact
      Name of Registrant as Specified in Its Charter)</b></font><br><font style="font-family: Times New Roman"><b>______________</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <b>DELAWARE</b><br><b>(State or Other Jurisdiction of Incorporation) </b>
    </p>
    <p style="text-align: center">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>1-36214</b>
          </p>
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>04-2902449</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(Commission File Number)</b>
          </p>
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>(I.R.S. Employer Identification No.)</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>250 Campus Drive, Marlborough, MA</b>
          </p>
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>01752</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt"><b>(Address
            of Principal Executive Offices)</b></font>
          </p>
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="bottom">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt"><b>(Zip
            Code)</b></font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <b>(508) 263-2900</b><br><b>(Registrant&#8217;s Telephone Number, Including
      Area Code) </b>
    </p>
    <p style="text-align: center">
      <b>(Former Name or Former Address, if Changed Since Last Report)</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman"><b>______________</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      &#160;&#160;<font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      &#160;&#160;<font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      &#160;&#160;<font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      &#160;&#160;<font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <p>

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Indicate by
      check mark whether the registrant is an emerging growth company as
      defined in Rule 405 of the Securities Act of 1933 (17 CFR&#160;&#167;230.405) or
      Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</font>
    </p>
    <p>
      Emerging growth company <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
    </p>
    <p>

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">If an
      emerging growth company, indicate by check mark if the registrant has
      elected not to use the extended transition period for complying with any
      new or revised financial accounting standards provided pursuant to
      Section 13(a) of the Exchange Act.</font> <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
    </p>
    <p>

    </p>
    <hr style="text-align: center; color: #000000; height: 3.0 pt; width: 100%">


    <p>

    </p>
    <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; margin-bottom: 10pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p>
      <b>Item&#160;2.02 Results of Operations and Financial Condition.</b>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      On January 7, 2019, Hologic, Inc. issued a press release announcing its
      preliminary revenue results for the first quarter ended December 29,
      2018. A copy of the press release is attached hereto as Exhibit&#160;99.1 and
      is incorporated herein in its entirety by reference.
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      <i><b>Limitation on Incorporation by Reference.</b></i>&#160;The information
      furnished in this Item&#160;2.02, including the press release attached hereto
      as Exhibit&#160;99.1,&#160;shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18
      of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
      or otherwise subject to the liabilities of that section, nor shall such
      information be deemed incorporated by reference in any filing under the
      Securities Act of 1933, as amended, or the Exchange Act except as set
      forth by specific reference in such a filing.
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      <i><b>Cautionary Note Regarding Forward-Looking Statements.&#160;</b></i>Except
      for historical information contained in the press release attached as an
      exhibit hereto, the press release contains forward-looking statements
      that involve certain risks and uncertainties that could cause actual
      results to differ materially from those expressed or implied by these
      statements. Please refer to the cautionary note in the press release
      regarding these forward-looking statements.
    </p>
    <p>

    </p>
    <p>
      <b>Item&#160;9.01 Financial Statements and Exhibits.</b>
    </p>
    <p>
      &#160;(d) Exhibits.
    </p>
    <p>
      <br>

    </p>
    <p style="white-space: nowrap">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid; width: 13%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Exhibit Number</b>
          </p>
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid; width: 85%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Description</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px; width: 13%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <a href="a51921394_ex991.htm">99.1</a>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 85%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <a href="a51921394_ex991.htm">Press release dated January 7, 2019
            of Hologic, Inc. announcing preliminary revenue results for the
            first quarter ended December 29, 2018.</a>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; margin-bottom: 10pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <u><font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font></u>
    </p>
    <p style="text-align: center">

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 5%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Date:
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 45%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            January 7, 2019
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px" valign="top" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            HOLOGIC, INC.
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="text-align: left; padding-left: 0.0px" valign="top" colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 5%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 45%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 4%" valign="top">
          By:
        </td>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid; width: 46%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            /s/ Karleen M. Oberton
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 4%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 46%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Karleen M. Oberton
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 4%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 46%" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Chief Financial Officer
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51921394_ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2019 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>Hologic
      Preliminary Revenues Increase Approximately 5% to $831 Million in First
      Quarter of Fiscal 2019</b></font>
    </p>
    <p>
      MARLBOROUGH, Mass.--(BUSINESS WIRE)--January 7, 2019--Hologic, Inc.
      (Nasdaq: HOLX) announced today preliminary revenue results for its first
      fiscal quarter ended December 29, 2018.
    </p>
    <p>
      The Company expects to report total revenues of approximately $831
      million, an increase of 5% compared to the prior year period, or 5.7% in
      constant currency. These preliminary results compare to the Company&#8217;s
      prior guidance range of $800 to $815 million. Revenues by division are
      expected to be:
    </p>
<div style="text-align:left">
    <table style="font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $s in millions
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          Preliminary

          <p style="margin-top: 0px; margin-bottom: 0px">
            Q1&#8217;19
          </p>
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          Q1&#8217;18
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          Diagnostics
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $297
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $285
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 15.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          <i>Diagnostics ex. Blood</i>
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          <i>$282</i>
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          <i>$272</i>
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          Breast Health
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $325
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $288
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          Medical Aesthetics
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $80
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $91
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          GYN Surgical
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $108
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $108
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          Skeletal Health
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $21
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $20
        </td>
      </tr>
      <tr>
        <td style="text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="top">
          Total
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $831
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="border-bottom-width: 1.0pt; border-bottom-color: black; border-bottom-style: solid">
          &#160;
        </td>
        <td style="text-align: center; white-space: nowrap; padding-right: 0.0px; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid" valign="bottom">
          $791
        </td>
      </tr>
    </table>
    </div>
    <p>
      &#8220;We expect to post strong first quarter revenue well above our guidance
      range, driven by acceleration in our largest businesses &#8211; U.S. breast
      health, international, and molecular diagnostics &#8211; all of which posted
      double-digit constant currency growth to start our year,&#8221; said Steve
      MacMillan, Hologic&#8217;s Chairman, President and Chief Executive Officer.
    </p>
    <p>
      Hologic is providing these updates in advance of the Company&#8217;s
      participation in the 37<sup>th</sup> Annual J.P. Morgan Healthcare
      Conference, which begins today. The Company will post its conference
      presentation to the investors section of its website at <u>www.investors.hologic.com</u>.
      Live webcasts of the Company&#8217;s presentation and question and answer
      session, which begin at&#160;11:30 a.m. Pacific Time&#160;on January 8, also may
      be accessed there.&#160;The webcasts will be available for 30 days.
    </p>
    <p>
      The preliminary revenue results described in this press release are
      estimates only and are subject to revision until the Company completes
      its close processes, including finalizing its adoption of ASC 606, <i>Revenue
      from Contracts with Customers</i>, and reports its full financial
      results for the first quarter of fiscal 2019 on January 30, 2019. Actual
      results may differ materially from those estimated.
    </p>
    <p>
      <u><b>Use of Non-GAAP Financial Measures</b></u>
    </p>
    <p>
      The Company has presented certain non-GAAP financial measures in this
      press release: constant currency percentage change in revenues. Constant
      currency calculations show reported current period revenues as if the
      foreign exchange rates remain the same as those in effect in the
      comparable prior year period. This non-GAAP financial measure should be
      considered supplemental to, and not a substitute for, financial
      information prepared in accordance with GAAP. The Company's definition
      of non-GAAP measures may differ from similarly titled measures used by
      others.
    </p>
    <p>
      The non-GAAP financial measure used in this press release adjusts for
      the impact of foreign currency exchange movements that can be highly
      variable or difficult to predict. The Company generally uses non-GAAP
      financial measures to facilitate management's financial and operational
      decision-making, including evaluation of Hologic's historical operating
      results and comparison to competitors' operating results. Non-GAAP
      financial measures reflect an additional way of viewing aspects of the
      Company's operations that, when viewed with GAAP results and the
      reconciliations to corresponding GAAP financial measures (when they
      become available), may provide a more complete understanding of factors
      and trends affecting Hologic's business.
    </p>
    <p>
      Because non-GAAP financial measures exclude the effect of items that
      increase or decrease the company's reported results of operations,
      management strongly encourages investors to review, when they become
      available, the Company's consolidated financial statements and publicly
      filed reports in their entirety.
    </p>
    <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; margin-bottom: 10pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <u><b>About Hologic, Inc.</b></u>
    </p>
    <p>
      Hologic, Inc. is an innovative medical technology company primarily
      focused on improving women's health and well-being through early
      detection and treatment. For more information on Hologic, visit&#160;<u>www.hologic.com</u>.
    </p>
    <p>
      Hologic and associated logos are trademarks and/or registered trademarks
      of Hologic, Inc. and/or its subsidiaries in the United States and/or
      other countries.
    </p>
    <p>
      <u><b>Forward-Looking Statements</b></u>
    </p>
    <p>
      This news release contains forward-looking information that involves
      risks and uncertainties, including statements relating to the Company&#8217;s
      anticipated revenue results for the first quarter of fiscal 2019. These
      forward-looking statements are based upon assumptions made by the
      Company as of the date hereof and are subject to known and unknown risks
      and uncertainties that could cause actual results to differ materially
      from those anticipated.
    </p>
    <p>
      Risks and uncertainties that could adversely affect the Company&#8217;s
      business and prospects, and otherwise cause actual results to differ
      materially from those anticipated, include without limitation: U.S.,
      European and general worldwide economic conditions and related
      uncertainties; the Company&#8217;s reliance on third-party reimbursement
      policies to support the sales and market acceptance of its products,
      including the possible adverse impact of government regulation and
      changes in the availability and amount of reimbursement and
      uncertainties for new products or product enhancements; uncertainties
      regarding healthcare reform legislation, budget reduction or other cost
      containment efforts; changes in guidelines, recommendations and studies
      published by various organizations that could affect the use of the
      Company&#8217;s products; risks associated with acquisitions, including,
      without limitation, the Company&#8217;s ability to successfully integrate
      acquired businesses, the risks that the acquired businesses may not
      operate as effectively and efficiently as expected even if otherwise
      successfully integrated; the risks of conducting business
      internationally; the risk of adverse exchange rate fluctuations on the
      Company&#8217;s international activities and businesses; the Company&#8217;s ability
      to predict accurately the demand for its products and develop strategies
      to address its markets successfully; and competition.
    </p>
    <p>
      The risks included above are not exhaustive. Other factors that could
      adversely affect the Company's revenue results are described in the
      filings made by the Company with the SEC. The Company expressly
      disclaims any obligation or undertaking to release publicly any updates
      or revisions to any such statements presented herein to reflect any
      change in expectations or any change in events, conditions or
      circumstances on which any such statements are based.
    </p>
    <p>
      SOURCE: Hologic, Inc.
    </p>
    <p>
      CONTACT:<br>Michael Watts<br>Vice President, Investor Relations and
      Corporate Communications<br>(858) 410-8588
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
